Protective effects of hesperidin derivatives and their stereoisomers against advanced glycation end-products formation

Abstract

The new RNase A-MGO assay system could be used for the screening of AGEs inhibitors and hesperidin, and its derivatives could be promising candidate adjuvants for the treatment of diabetes complication, and age-related chronic diseases.